LOS ANGELES, April 19, 2018 -- With April being Alcohol Awareness Month, studies show 83% of people who drink excessively received no advice or encouragement from family and friends to cut down their drinking. Women with drinking problems were much less likely than men to receive advice with only 11.7% of them encouraged to seek help.
Using alcohol is socially acceptable and often even encouraged, despite the very real risks of substance abuse and health issues. According to a study published in JAMA Psychiatry, a staggering 1 in 8 Americans struggle with alcohol abuse.
“Hearing from friends or family that they might need help with alcohol is one of the main factors in people seeking treatment. And the sooner they get help, the sooner they can go on with their lives with a healthier relationship with alcohol,” says Dr. Diane Rothon, Medical Director for alcohol recovery program Alavida Health.
Only 10% of addicts ever get treatment
“The key to helping Americans with alcohol use disorder lies in having open and honest conversations about alcohol, helping people identify they have a problem, and finding them the right type of help to treat their addiction,” Dr. Rothon says.
Once someone has identified that they need help, finding the right kind of treatment is the next step. There are plenty of options, from traditional 12-step programs like AA to more revolutionary treatments such as Alavida Health, a science-based treatment program that promotes controlled drinking therapy instead of abstinence and touts a 75% success rate.
About Alavida
Alavida Health is a science-based treatment program that combines non-addictive medication, behavioral therapy and technology to help people decrease or stop their consumption of alcohol. Alavida clients work with their doctor and therapist for typically four to six months and can access their doctors in person or virtually, making the access barrier-free. Available in North America since 2016, Alavida currently has offices in Canada and the USA. The treatment model has a success rate of over 75 percent, in line with a clinical study and 20 years of ongoing practice conducted in Finland. More information about Alavida and how treatment works can be found at www.alavida.co.
Contact:
Binu Koshy
Media Relations
P: 905-617-1988 / 1-888-315-8550
E: [email protected]
Christine Gomes
Marketing Manager
E: [email protected]


GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Bain Capital Secures RBI Approval to Acquire Up to 41.7% Stake in Manappuram Finance
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle 



